BOSTON (July 15, 2013) — International law firm McDermott Will & Emery LLP announced today the launch of its Life Sciences Entrepreneurs Acceleration Program (LEAP) to help emerging and early-stage life sciences companies to grow by offering affordable access to strategic legal advice from one of the world’s premier law firms. Specifically, the Firm has committed $1 million in deferred billable time to fund the program, which is aimed at providing organizations and individuals with high-quality legal services during the earliest and most critical stages of growth in areas such as financing, intellectual property, licensing, employee benefits, and regulatory compliance.
The LEAP program will initially target a limited number of emerging and early-stage companies on their way to being funded or achieving a point of successful liquidity. McDermott will engage these companies, many of which have the potential to bring innovative and revolutionary products and services to market, through a variety of incentives including deferred fee, discounts, fixed fee arrangements and/or awards.
“We are excited to kick-start this program and begin partnering with the life sciences leaders of tomorrow,” said Byron S. Kalogerou, partner and Chair of McDermott’s Life Science Industry Group. “Life sciences start-up companies typically have a high demand for sophisticated legal services as they work to make it to the next level. McDermott intends to mobilize our wide- ranging resources, across multiple top-ranked practice groups, to help those companies realize their full potential.”
Companies wishing to participate in the LEAP program must be sponsored by a McDermott partner and work with the Firm to complete and submit an application to the LEAP Committee. The Committee, made up of McDermott lawyers, evaluates the prospect to determine if it qualifies for LEAP. This review is based on various criteria, including quality of the business plan, the ability of candidate to achieve milestones, and the current investment outlook.
McDermott provides fully integrated, multidisciplinary legal services to the life sciences industry. The Firm's group of 135+ lawyers, patent agents and scientific advisors provides the full range of legal services required by life sciences companies, regardless of their stage of development. The corporate lawyers in McDermott's Life Sciences Group work with clients in all stages of development, from formation through exits, such as dispositions and public offerings. McDermott also represents a range of investors, investment banks, venture capital firms and large medical device and pharmaceutical companies. The Firm has significant experience in representing life sciences companies and private equity investors in the full range of private and public financing transactions.
Applications are now open for submission. For more information on how to get started, please visit www.mwe.com/leap.
About McDermott Will & Emery
McDermott Will & Emery is a premier international law firm with a diversified business practice. Numbering more than 1,100 lawyers, we have offices in Boston, Brussels, Chicago, Düsseldorf, Frankfurt, Houston, London, Los Angeles, Miami, Milan, Munich, New York, Orange County, Paris, Rome, Seoul, Silicon Valley and Washington, D.C. Further extending our reach into Asia, we have a strategic alliance with MWE China Law Offices in Shanghai.